Catalyst
Slingshot members are tracking this event:
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
SGMO |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda Clearance, Ind, Zfn-media Genome, Sb-318, Sb-318-1502, Mucopolysaccharidosis Type I